OpenAI is collaborating with Los Alamos National Laboratory (LANL) — the institution behind the creation of the first nuclear weapon — to explore the application of AI in bioscience research. In a statement released on July 9, OpenAI announced its partnership with LANL’s bioscience division to assess how AI models like GPT-4 can aid scientists in performing tasks within a physical laboratory setting.
“This includes biological safety evaluations for GPT-4o and its yet-to-be-released real-time voice systems to determine their potential in supporting bioscience research,” OpenAI stated.
Established in 1943 with the primary objective of designing and constructing the world’s first atomic bomb, Los Alamos National Laboratory (LANL) spent nearly 50 years primarily engaged in high-level military research. However, following the end of the Cold War in 1991, LANL transitioned its focus to civilian research and development.
Today, LANL’s bioscience division engages in a wide array of research areas, including vaccine development, sustainability biotechnology, the impact of climate change on disease emergence, and various forms of biothreat detection.
So relax, it’s all for bioscience
GPT-4o, OpenAI’s latest multimodal large language model, enables users to interact with the chatbot using voice, imagery, and text in real-time.
The partnership with Los Alamos National Laboratory (LANL) encompasses various tasks, including cell transformation (introducing foreign genetic material into a host organism), cell culture, and cell separation.
OpenAI stated that this collaboration would expand upon its previous bioscience efforts in two main areas: incorporating “wet lab techniques” to train models for more complex tasks like mass spectrometry, and exploring new “modalities” of AI use in lab settings. GPT-4o’s voice and visual inputs are expected to open new avenues for potentially expediting learning among scientists.
Additionally, OpenAI noted that its work with LANL would contribute to ongoing efforts to address biothreat risks.
The new partnership comes at a time when major tech companies, including Microsoft and Apple, are distancing themselves from OpenAI due to increasing regulatory concerns.
On July 10, Microsoft sent a letter to OpenAI announcing its withdrawal from the board, just one year after investing $13 billion in the AI startup.
In June, European Union regulators revealed that OpenAI could face an antitrust investigation over its partnership with Microsoft.